70 related articles for article (PubMed ID: 22956143)
1. Antagomirbase- a putative antagomir database.
Ganguli S; Mitra S; Datta A
Bioinformation; 2011; 7(1):41-3. PubMed ID: 21904438
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue macrophages secrete small extracellular vesicles that mediate rosiglitazone-induced insulin sensitization.
Rohm TV; Castellani Gomes Dos Reis F; Isaac R; Murphy C; Cunha E Rocha K; Bandyopadhyay G; Gao H; Libster AM; Zapata RC; Lee YS; Ying W; Miciano C; Wang A; Olefsky JM
Nat Metab; 2024 May; 6(5):880-898. PubMed ID: 38605183
[TBL] [Abstract][Full Text] [Related]
3. Advances and Obstacles in Using CRISPR/Cas9 Technology for Non-Coding RNA Gene Knockout in Human Mesenchymal Stromal Cells.
Basalova N; Illarionova M; Skryabina M; Vigovskiy M; Tolstoluzhinskaya A; Primak A; Chechekhina E; Chechekhin V; Karagyaur M; Efimenko A
Noncoding RNA; 2023 Aug; 9(5):. PubMed ID: 37736895
[TBL] [Abstract][Full Text] [Related]
4. Symbiosis preservation: Putative regulation of fatty acyl-CoA reductase by miR-31a within the symbiont harboring bacteriome through tsetse evolution.
Lee MH; Hu G; Rio RVM
Front Microbiol; 2023; 14():1151319. PubMed ID: 37113220
[TBL] [Abstract][Full Text] [Related]
5. Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies.
Fàbrega C; Aviñó A; Navarro N; Jorge AF; Grijalvo S; Eritja R
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839642
[TBL] [Abstract][Full Text] [Related]
6. Thyclotides, tetrahydrofuran-modified peptide nucleic acids that efficiently penetrate cells and inhibit microRNA-21.
Clausse V; Zheng H; Amarasekara H; Kruhlak M; Appella DH
Nucleic Acids Res; 2022 Oct; 50(19):10839-10856. PubMed ID: 36215040
[TBL] [Abstract][Full Text] [Related]
7. The role of microRNA in the pathogenesis of glial brain tumors.
Beylerli O; Gareev I; Sufianov A; Ilyasova T; Zhang F
Noncoding RNA Res; 2022 Jun; 7(2):71-76. PubMed ID: 35330864
[TBL] [Abstract][Full Text] [Related]
8. Hormonal regulation of microRNA expression dynamics in the gut of the yellow fever mosquito
Zhang X; Raikhel AS
RNA Biol; 2021 Nov; 18(11):1682-1691. PubMed ID: 33317406
[TBL] [Abstract][Full Text] [Related]
9. Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.
Malik S; Lim J; Slack FJ; Braddock DT; Bahal R
J Control Release; 2020 Nov; 327():406-419. PubMed ID: 32835710
[TBL] [Abstract][Full Text] [Related]
10. Editorial focus: understanding off-target effects as the key to successful RNAi therapy.
Bartoszewski R; Sikorski AF
Cell Mol Biol Lett; 2019; 24():69. PubMed ID: 31867046
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of Anti microRNA-124 and -137 Oligonucleotides Prevents Hippocampal Neural Stem Cell Loss Upon Non-convulsive Seizures.
Bielefeld P; Schouten M; Meijer GM; Breuk MJ; Geijtenbeek K; Karayel S; Tiaglik A; Vuuregge AH; Willems RAL; Witkamp D; Lucassen PJ; Encinas JM; Fitzsimons CP
Front Mol Neurosci; 2019; 12():31. PubMed ID: 30837840
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs and cancer: Key paradigms in molecular therapy.
Tan W; Liu B; Qu S; Liang G; Luo W; Gong C
Oncol Lett; 2018 Mar; 15(3):2735-2742. PubMed ID: 29434998
[TBL] [Abstract][Full Text] [Related]
13. The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.
Beyer S; Fleming J; Meng W; Singh R; Haque SJ; Chakravarti A
Cancers (Basel); 2017 Jul; 9(7):. PubMed ID: 28698530
[TBL] [Abstract][Full Text] [Related]
14. Monitoring integrity and localization of modified single-stranded RNA oligonucleotides using ultrasensitive fluorescence methods.
Heissig P; Schrimpf W; Hadwiger P; Wagner E; Lamb DC
PLoS One; 2017; 12(3):e0173401. PubMed ID: 28278199
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated expression of microRNAs and mRNAs in myocardial infarction.
Wang Y; Pan X; Fan Y; Hu X; Liu X; Xiang M; Wang J
Am J Transl Res; 2015; 7(11):2291-304. PubMed ID: 26807177
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity.
Velu CS; Chaubey A; Phelan JD; Horman SR; Wunderlich M; Guzman ML; Jegga AG; Zeleznik-Le NJ; Chen J; Mulloy JC; Cancelas JA; Jordan CT; Aronow BJ; Marcucci G; Bhat B; Gebelein B; Grimes HL
J Clin Invest; 2014 Jan; 124(1):222-36. PubMed ID: 24334453
[TBL] [Abstract][Full Text] [Related]
17. From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).
Piva R; Spandidos DA; Gambari R
Int J Oncol; 2013 Oct; 43(4):985-94. PubMed ID: 23939688
[TBL] [Abstract][Full Text] [Related]
18. Utilizing antagomiR (antisense microRNA) to knock down microRNA in murine bone marrow cells.
Velu CS; Grimes HL
Methods Mol Biol; 2012; 928():185-95. PubMed ID: 22956143
[TBL] [Abstract][Full Text] [Related]
19. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer.
Lai X; Eberhardt M; Schmitz U; Vera J
Nucleic Acids Res; 2019 Sep; 47(15):7753-7766. PubMed ID: 31340025
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]